mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.12 |
0.02 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.02 |
mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
0.082 |
0.02 |
mRNA |
BRD-K29313308 |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.02 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.02 |
mRNA |
AZD4547 |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.03 |
mRNA |
PFI-1 |
GDSC1000 |
pan-cancer |
AAC |
0.079 |
0.03 |
mRNA |
tamatinib |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.03 |
mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.03 |
mRNA |
KU-55933 |
GDSC1000 |
pan-cancer |
AAC |
0.087 |
0.03 |